Samarendra Mohanty

Samarendra Mohanty

Company: Nanoscope Therapeutics

Job title: Chief Scientific Officer & President


Exploring Ambient Light Activatable Optogenetics for Vision Restoration in Retinal Degenerative Diseases 9:00 am

Mutation-agnostic therapy with potential to be disease-agnostic platform therapy preclinical data Clinical data on Retinitis Pigmentosa Novel end points for low vision patients deployed in a multi-site randomized, sham-controlled optogenetic studyRead more

day: Day Two

Panel Discussion: Gene Therapy for Ophthalmic Disorders – A Year in Review 8:25 am

Developments and setback in the last 12 months Overview of instrumental work that has worked towards solving major issues Discussing the sustainability of ophthalmic gene therapy What does the coming year look like?Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.